ArticleJournal of medical physics
Investigation of the Impact of Vaginal Marker Utilization on Radiotherapy Treatment Plans Created with Various Planning Systems in Endometrial Cancer Patients.
Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Our aim is to compare treatment plans with vaginal markers used in radiotherapy target volume definition with those without markers, which we have not encountered in our literature searches, and to investigate whether patients with endometrial cancer (EC) can undergo treatment with a single simulation tomography. Materials and Methods: A total of twenty patients with EC were randomly selected. All patients underwent a computerized tomography in the supine position. During the scan, the arms were folded over the chest, and the feet were fixed with a foot immobilizer. Tomography scans were performed with a vaginal marker. A total of four treatment plans were made by a medical physicist using tomography images with both vaginal markers (CT Set 1) and 0 Hounsfield units assigned to the vaginal marker (CT Set 2) under the same conditions. Results: The mean doses of maximum and mean of planning target volume (PTV) and critical organs were derived from the data obtained from the treatment plans created using CT Set 1 and CT Set 2. No significant differences were observed regarding PTV or critical organs when comparing the plans of CT Set 1 and CT Set 2 in both Treatment Planning Systems. Conclusions: Dosimetric comparison of plans with and without vaginal markers, no difference was found in terms of dosimetric parameters. Therefore, we suggested that a clinical decision can be made to plan with vaginal markers, thus ensuring that the patient does not receive an unnecessary second tomography dose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.